Related Experiment Videos
In vitro characterization of a membrane-based low-density lipoprotein affinity adsorption device
1University of Wisconsin, Madison, USA.
Blood Purification
|July 29, 1998
Summary
Microporous membranes offer a novel substrate for low-density lipoprotein (LDL) removal, enabling efficient therapeutic apheresis. This approach significantly reduces device volume while maintaining high adsorption capacity for LDL cholesterol.
Area of Science:
- Biomedical Engineering
- Materials Science
- Biochemistry
Background:
- Therapeutic apheresis aims to remove harmful lipoproteins, such as low-density lipoprotein (LDL), from patient plasma.
- Conventional methods often utilize porous beads as affinity substrates, which can be bulky and less efficient in transport.
- Developing alternative substrates with enhanced properties is crucial for improving apheresis efficacy and patient outcomes.
Purpose of the Study:
- To investigate microporous membranes as a viable alternative to porous beads for LDL affinity adsorption.
- To evaluate the performance of immunoaffinity membranes in capturing LDL from plasma for therapeutic applications.
- To assess the efficiency of adsorption, elution, and regeneration cycles for potential clinical use.
Main Methods:
- Covalent immobilization of polyclonal antibodies onto flat sheet microporous membranes via a poly(ethylene glycol) (PEG) spacer.
- Measurement of equilibrium adsorption of LDL from human plasma.
- Investigation of LDL adsorption and elution dynamics as a function of flow rate using citrate buffer.
- Assessment of specific adsorption capacity and the number of adsorptive cycles achievable.
Main Results:
- Achieved a specific capacity as high as 2 mg apolipoprotein B per milliliter of membrane volume.
- Demonstrated superior transport properties of membranes, enabling rapid LDL adsorption and efficient regeneration.
- Facilitated a high number of adsorptive cycles within a given treatment time.
- Estimated an 80% reduction in device volume compared to packed columns for comparable LDL reduction.
Conclusions:
- Microporous membranes represent a promising alternative substrate for immunoaffinity adsorption of LDL.
- The enhanced transport properties and high capacity of these membranes lead to efficient and rapid LDL removal.
- Immunoaffinity membrane devices offer a significant reduction in volume, potentially improving therapeutic apheresis treatments.